Molecular POCT Diagnostics Research:CAGR of 9.7% during the forecast period

Molecular POCT Diagnostics Market Summary

Molecular POCT (Point-of-Care Testing) Diagnostics refers to a diagnostic method that enables the detection of molecular markers-such as nucleic acids (DNA, RNA) or proteins-in biological samples (e.g., blood, saliva, or nasal swabs) directly at or near the site of patient care. Unlike traditional laboratory-based tests, which require sending samples to a central lab for analysis, molecular POCT diagnostics allow for rapid and decentralized testing, often providing results in real-time. This type of testing typically involves molecular techniques like PCR (Polymerase Chain Reaction), LAMP (Loop-mediated Isothermal Amplification), or CRISPR-based assays to identify specific genetic material from pathogens or disease-related biomarkers.

The main advantage of Molecular POCT Diagnostics is its ability to deliver accurate, timely, and actionable results at the point of care, which is crucial for early disease detection, monitoring, and treatment decisions. This technology is particularly beneficial in infectious disease management, such as for COVID-19, respiratory infections, or sexually transmitted infections, where quick results are necessary for effective intervention. The portability, ease of use, and speed of these molecular diagnostic devices have expanded their use in diverse settings, including hospitals, clinics, remote areas, and even at home, making them a game-changer in personalized and proactive healthcare.

According to the new market research report "Global 'Molecular POCT Diagnostics Market Report 2024-2030", published by QYResearch, the global 'Molecular POCT Diagnostics market size is projected to reach USD 10.13 billion by 2030, at a CAGR of 9.7% during the forecast period.

Global Molecular POCT Diagnostics MarketSize(US$ Million), 2019-2030
241210-162348.webp (14 KB)

Above data is based on report from QYResearch: Global Molecular POCT Diagnostics Market Report 2024-2030 (published in 2024). If you need the latest data, plaese contact QYResearch.



Global Molecular POCT Diagnostics Top12Players Ranking and Market Share (Ranking is based on the revenue of 2023, continually updated)
241210-162412.webp (16 KB)

Above data is based on report from QYResearch: Global Molecular POCT Diagnostics Market Report 2024-2030 (published in 2024). If you need the latest data, plaese contact QYResearch.

According to QYResearch Top Players Research Center, the global key manufacturers of 'Molecular POCT Diagnostics include Danaher, bioMérieux, Roche, Abbott, Thermo Fisher Scientific, etc. In 2023, the global top five players had a share approximately 94.0% in terms of revenue.



Molecular POCT Diagnostics,Global Market Size, Split by Product Segment
241210-162443.webp (24 KB)

Based on or includes research from QYResearch: Global Molecular POCT Diagnostics Market Report 2024-2030.

In terms of product type, currently Reagents Consumables is the largest segment, hold a share of 82.5%.

In terms of product application, currently Hospital is the largest segment, hold a share of 41.9%.

Molecular POCT (Point-of-Care Testing) diagnostics are showing a rapid growth trend in the global medical market. With the outbreak of the COVID-19 pandemic, the demand for molecular POCT has been driven unprecedentedly. Molecular POCT technology enables disease detection to shift from traditional laboratory processes to immediate and convenient on-site testing, reducing waiting time for testing and improving diagnostic efficiency. Portable and rapid molecular testing equipment is becoming increasingly popular in primary care and remote areas, allowing high-precision molecular testing to be performed in areas with insufficient medical resources. The development of such products makes the detection of infectious diseases (such as influenza, tuberculosis, sexually transmitted diseases, etc.) more convenient and improves public health.

About Us：

QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 17 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.

Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
Email: global@qyresearch.com
Tel: 001-626-842-1666(US)  
JP: https://www.qyresearch.co.jp

This release was published on openPR.